These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 8619827)

  • 1. Vasopressor activities of N-terminal fragments of adrenomedullin in anesthetized rat.
    Watanabe TX; Itahara Y; Inui T; Yoshizawa-Kumagaye K; Nakajima K; Sakakibara S
    Biochem Biophys Res Commun; 1996 Feb; 219(1):59-63. PubMed ID: 8619827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of adrenomedullin, a novel vasodilatory peptide, in cultured rat vascular smooth muscle cells.
    Eguchi S; Hirata Y; Iwasaki H; Sato K; Watanabe TX; Inui T; Nakajima K; Sakakibara S; Marumo F
    Endocrinology; 1994 Dec; 135(6):2454-8. PubMed ID: 7988431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human proadrenomedullin N-terminal 20 peptide in pheochromocytoma and normal adrenal medulla.
    Kuwasako K; Kitamura K; Ichiki Y; Kato J; Kangawa K; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1995 Jun; 211(2):694-9. PubMed ID: 7794284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and biological activities of rat adrenomedullin, a hypotensive peptide.
    Sakata J; Shimokubo T; Kitamura K; Nakamura S; Kangawa K; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1993 Sep; 195(2):921-7. PubMed ID: 7690563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of hypotensive effect of chronically infused proadrenomedullin N-terminal 20 peptide in rats.
    Matsui E; Kato J; Kitmara K; Eto T
    Horm Metab Res; 1998 Sep; 30(9):555-6. PubMed ID: 9808322
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.
    Kitamura K; Kangawa K; Kawamoto M; Ichiki Y; Nakamura S; Matsuo H; Eto T
    Biochem Biophys Res Commun; 1993 Apr; 192(2):553-60. PubMed ID: 8387282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proadrenomedullin NH2-terminal peptide (PAMP)(12-20) has vasodepressor activity in the rat and cat.
    Fry RC; Champion HC; Lawrence TC; Murphy WA; Coy DH; Kadowitz PJ
    Life Sci; 1997; 60(10):PL161-7. PubMed ID: 9064471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycine-extended adrenomedullin exerts vasodilator effect through amidation in the rat aorta.
    Cao YN; Kitamura K; Ito K; Kato J; Hashida S; Morishita K; Eto T
    Regul Pept; 2003 May; 113(1-3):109-14. PubMed ID: 12686469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides.
    Hollenberg MD; Saifeddine M; al-Ani B; Kawabata A
    Can J Physiol Pharmacol; 1997 Jul; 75(7):832-41. PubMed ID: 9315351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced sensitivity of fa/fa Zucker rats to adrenomedullin.
    Chan CB; Johnson KJ
    Can J Physiol Pharmacol; 1997 Sep; 75(9):1138-41. PubMed ID: 9365826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenomedullin modulates COX-2 and HGF expression in reserpine-injuried gastric mucosa in the rat.
    Cantarella G; Martinez G; Cutuli VM; Loreto C; D'Alcamo M; Prato A; Amico-Roxas M; Bernardini R; Clementi G
    Eur J Pharmacol; 2005 Aug; 518(2-3):221-6. PubMed ID: 16081063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoreactive adrenomedullin in human adrenal glands and adrenal tumors.
    Satoh F; Takahashi K; Murakami O; Totsune K; Sone M; Ohneda M; Abe K; Miura Y; Mouri T
    Cancer Detect Prev; 1997; 21(1):51-4. PubMed ID: 9043763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoactive effects of adrenotensin and its interactions with adrenomedullin.
    Zhou L; Qiu Z; Ye C; Di L; Liu X; Tang C; Zhao Y
    Chin Med J (Engl); 2000 Mar; 113(3):269-71. PubMed ID: 11775262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An adrenomedullin fragment retains the systemic vasodepressor activity of rat adrenomedullin.
    Lin B; Gao Y; Chang JK; Heaton J; Hyman A; Lippton H
    Eur J Pharmacol; 1994 Jul; 260(1):1-4. PubMed ID: 7957618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adrenomedullin].
    Bełtowski J
    Postepy Hig Med Dosw; 1999; 53(1):99-123. PubMed ID: 10352550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of potent, highly selective vasopressin hypotensive agonists.
    Stoev S; Cheng LL; Manning M; Wo NC; Szeto HH
    J Pept Sci; 2006 Sep; 12(9):592-604. PubMed ID: 16625682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central mechanisms for the hypertensive effects of preproadrenomedullin-derived peptides in conscious rats.
    Samson WK; Murphy TC; Resch ZT
    Am J Physiol; 1998 May; 274(5):R1505-9. PubMed ID: 9612421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic human adrenomedullin and adrenomedullin 15-52 have potent short-lived vasodilator activity in the hindlimb vascular bed of the cat.
    Santiago JA; Garrison EA; Ventura VL; Coy DH; Bitar K; Murphy WA; McNamara DB; Kadowitz PJ
    Life Sci; 1994; 55(5):PL85-90. PubMed ID: 8035644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity investigation of novel vasopressin hypotensive peptide agonists.
    Manning M; Stoev S; Cheng LL; Wo NC; Chan WY
    J Pept Sci; 1999 Nov; 5(11):472-90. PubMed ID: 10587312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adrenomedullin and PAMP: discovery, structures, and cardiovascular functions.
    Kitamura K; Kangawa K; Eto T
    Microsc Res Tech; 2002 Apr; 57(1):3-13. PubMed ID: 11921351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.